BioCorRx Inc To Present At The Q1 Investor Summit Conference Transcript

Mar 09, 2022 / 08:30PM GMT
Operator

Welcome everybody to the Q1 2022 Investor Summit. We have here today Brady Granier, the President and Director of BioCorRx, as well as the CEO and founder of BioCorRx Pharmaceuticals.

(Operator Instructions) So, that's it. And, Brady, take it away.

Brady Granier - BioCorRx, Inc. - President & CEO

Thanks. Appreciate it. Thanks for everybody in advance for joining the presentation today. I will first start off with the usual Safe Harbor statement for everyone to review. This is posted on our website as well for anyone that wants to really read this, you're welcome to do so. I'll start off with kind of the company corporate structure. We have BioCorRx, Inc., which is the parent company, the holding company. And then underneath that company, we have two business lines, UnCraveRx and Beat Addiction Recovery, which we'll talk about towards the second half of the presentation. And then, we also are a majority owner of a pharmaceutical subsidiary, BioCorRx Pharmaceuticals. And I'll talk more about that in the first half of the presentation.

So, a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot